Hydatidiform moles: Ancillary techniques to refine diagnosis

International Journal of Gynecological Pathology

Volumn 30, Issue 2, 2011, Pages 101-116

  Ronnett, Brigitte M ^a   Descipio, Cheryl ^a   Murphy, Kathleen M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ProPath   (United States)

Author keywords

Hydatidiform mole; Molecular genotyping; p57 immunohistochemistry

Indexed keywords

PROTEIN P57;

FEMALE; GENOTYPE; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TROPHOBLASTIC TUMOR;

FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; PREGNANCY; UTERINE NEOPLASMS;

EID: 79951768223     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/PGP.0b013e3181f4de77     Document Type: Review

References (50)

1. Sebire NJ, Fisher RA, Rees HC. Histopathological diagnosis of partial and complete hydatidiform mole in the first trimester of (Pubitemid 36323629)
2. Sebire NJ, Makrydimas G, Agnantis NJ, et al. Updated diagnostic criteria for partial and complete hydatidiform moles in early pregnancy. Anticancer Res 2003;23:1723-8. (Pubitemid 36750838)
3. Szulman AE, Surti U. The syndromes of hydatidiform mole. II. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 1978;132:20-7. (Pubitemid 8397361)
4. Keep D, Zaragoza MV, Hassold T, et al. Very early complete hydatidiform mole. Hum Pathol 1996;27:708-13. (Pubitemid 26240324)
5. Fukunaga M. Histopathologic study of partial hydatidiform moles and DNA triploid placentas. Pathol Int 1994;44:528-34. (Pubitemid 24210994)
6. Fukunaga M. Early partial hydatidiform mole: prevalence, histopathology, DNA ploidy, and persistence rate. Virchows Arch 2000;437:180-4. (Pubitemid 30623578)
7. Conran RM, Hitchcock CL, Popek EJ, et al. Diagnostic considerations in molar gestations. Hum Pathol 1993;24:41-8. (Pubitemid 23046671)
8. Fukunaga M, Katabuchi H, Nagasaka T, et al. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol 2005;29:942-7. (Pubitemid 40885018)
9. Howat AJ, Beck S, Fox H, et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol 1993;46:599-602.
10. Chew SH, Perlman EJ, Williams R, et al. Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). Hum Pathol 2000;31:914-24.
11. McConnell TG, Murphy KM, Hafez M, et al. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol 2009;33:805-17.
12. Deavers MT, Kalhor N, Silva EG. Diagnostic problems with trophoblastic lesions. Arch Pathol Lab Med 2008;132:168-74. (Pubitemid 351213781)
13. Hoffner L, Dunn J, Esposito N, et al. p57kip2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/ chimeric conceptions. Hum Pathol 2008;39:63-72. (Pubitemid 350216161)
14. Sebire NJ, Fisher RA, Foskett M, et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG 2003;110:22-6. (Pubitemid 36034289)
15. Berkowitz RS, Goldstein DP. Diagnosis and management of the primary hydatidiform mole. Obstet Gynecol Clin North Am 1988;15:491-503.
16. Berkowitz RS, Tuncer ZS, Bernstein MR, et al. Management of gestational trophoblastic diseases: subsequent pregnancy experience. Semin Oncol 2000;27:678-85.
17. Garner EI, Goldstein DP, Feltmate CM, et al. Gestational trophoblastic disease. Clin Obstet Gynecol 2007;50:112-22. (Pubitemid 46279854)
18. Berkowitz RS, Goldstein DP. Current management of gestational trophoblastic diseases. Gynecol Oncol 2009;112:654-62.
19. Feltmate CM, Growdon WB, Wolfberg AJ, et al. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med 2006;51:902-6. (Pubitemid 44788839)
20. Wielsma S, Kerkmeijer L, Bekkers R, et al. Persistent trophoblast disease following partial molar pregnancy. Aust N Z J Obstet Gynaecol 2006;46:119-23.
21. Palmieri C, Fisher RA, Sebire NJ, et al. Placental site trophoblastic tumour arising from a partial hydatidiform mole. Lancet 2005;366:688. (Pubitemid 41176023)
22. Seckl MJ, Fisher RA, Salerno G, et al. Choriocarcinoma and partial hydatidiform moles. Lancet 2000;356:36-9. (Pubitemid 30416993)
23. Sebire NJ, Foskett M, Fisher RA, et al. Persistent gestational trophoblastic disease is rarely, if ever, derived from non-molar first-trimester miscarriage. Med Hypotheses 2005;64:689-93. (Pubitemid 40203053)
24. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 1998;78:269-76. (Pubitemid 28128890)
25. Jun SY, Ro JY, Kim KR. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. J Urol 2003;43:17-25. (Pubitemid 36836583)
26. Castrillon DH, Sun D, Weremowicz S, et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57kip2. Am J Surg Pathol 2001;25:1225-30. (Pubitemid 32917114)
27. Popiolek DA, Yee H, Mittal K, et al. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(kip2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol 2006;37:1426-34. (Pubitemid 44584331)
28. Bell KA, Vand V, Addya K, et al. Molecular genetic testing from paraffin-embedded tissue distinguishes nonmolar hydropic abortion from hydatidiform mole. Mol Diagn 1999;4:11-19.
29. Bifulco C, Johnson C, Hao L, et al. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol 2008;32:445-51. (Pubitemid 351398937)
30. Redline RW, Hassold T, Zaragoza BS. Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin. Hum Pathol 1998;29:505-11. (Pubitemid 28213471)
31. Zaragoza MV, Surti U, Redline RW, et al. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet 2000;66:1807-20. (Pubitemid 30480088)
32. Kaiser-Rogers KA, McFadden DE, Livasy CA, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 2006;43:187-92. (Pubitemid 43259636)
33. Murphy KM, McConnell TG, Hafez MJ, et al. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay. J Mol Diagn 2009;11:598-605.
34. McConnell TG, Norris-Kirby A, Hagenkord JM, et al. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol 2009;33:1409-15.
35. Norris-Kirby A, Hagenkord JM, Kshirsagar M, et al. Abnormal villous morphology associated with triple trisomy of paternal origin. J Mol Diagn 2010;12:525-9.
36. Fukunaga M. Immunohistochemical characterization of p57(kip2) expression in early hydatidiform moles. Hum Pathol 2002;33:1188-92. (Pubitemid 36020068)
37. Fukunaga M. Immunohistochemical characterization of p57kip2 expression in tetraploid hydropic placentas. Arch Pathol Lab Med 2004;128:897-900. (Pubitemid 39014124)
38. Fisher RA, Nucci MR, Thaker HM, et al. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol 2004;17:1155-60. (Pubitemid 39128243)
39. Lage JM,Mark SD, Roberts DJ, et al. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol 1992;79:403-10.
40. Lage JM, Popek EJ. The role of DNA flow cytometry in evaluation of partial and complete hydatidiform moles and hydropic abortions. Semin Diagn Pathol 1993;10:267-74. (Pubitemid 23228390)
41. Lescoat D, Jouan H, Loeuillet-Olivo L, et al. Fluorescent in situ hybridization (FISH) on paraffin-embedded placental tissues as an adjunct for understanding the etiology of early spontaneous abortion. Prenat Diagn 2005;25:314-7. (Pubitemid 40632266)
42. Yver M, Carles D, Bloch B, et al. Determination of DNA ploidy by fluorescence in situ hybridization (FISH) in hydatidiform moles: evaluation of FISH on isolated nuclei. Hum Pathol 2004;35:752-8. (Pubitemid 38881087)
43. Ambani LM, Vaidya RA, Rao CS, et al. Familial occurrence of trophoblastic disease-report of recurrent molar pregnancies in sisters in three families. Clin Genet 1980;18:27-29. (Pubitemid 10048744)
44. Williams D, Hodgetts V, Gupta J. Recurrent hydatidiform moles. Eur J Obstet Gynecol Reprod Biol 2010;150:3-7.
45. Van den Veyver I, Al-Hussaini TK. Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring. Hum Reprod Update 2006;12:233-42.
46. Hayward BE, De VM, Talati N, et al. Genetic and epigenetic analysis of recurrent hydatidiform mole. Hum Mutat 2009;30:E629-39.
47. Kou YC, Shao L, Peng HH, et al. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. Mol Hum Reprod 2008;14:33-40. (Pubitemid 351267224)
48. El-Maarri O, Seoud M, Riviere JB, et al. Patients with familial biparental hydatidiform moles have normal methylation at imprinted genes. Eur J Hum Genet 2005;13:486-90. (Pubitemid 40520940)
49. Fisher RA, Hodges MD, Newlands ES. Familial recurrent hydatidiform mole: a review. J Reprod Med 2004;49:595-601. (Pubitemid 39128773)
50. Fisher RA, Khatoon R, Paradinas FJ, et al. Repetitive complete hydatidiform mole can be biparental in origin and either male or female. Hum Reprod 2000;15:594-8.